Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Humoral Hypercalcemia Of Malignancy × parathyroid hormone-related peptide (1-36) × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Osteoporosis 1 Neoplasms 1 Musculoskeletal Diseases 1 Hyperparathyroidism 1 Humoral Hypercalcemia Of Malignancy 1 Endocrine System Diseases 1

Interventions

parathyroid hormone-related peptide (1-36) 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00580788 2016-02-11

One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study

University of Pittsburgh

Phase EARLY_PHASE1 Completed

14 enrolled 16 charts

Humoral Hypercalcemia Of Malignancy, Endocrine System Diseases, Hyperparathyroidism, Musculoskeletal Diseases, Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡